|
Subsample
|
Positive clinical status score*; number (%)
|
Cognitive outcome IQ <85; number (%)
|
|---|
|
Symptomatic group
|
3/6 (50)
|
4/6 (66.7)
|
|
High risk group
|
1/7 (14.3)
|
3/7 (42.9)
|
|
NBS without MCADD and PKU
|
12/30 (40.0)
|
2/26 (7.7)
|
|
NBS: MCADD
|
3/32 (9.4)
|
1/32 (3.1)
|
|
NBS: PKU
|
7/50 (14.0)
|
4/49 (8.2)
|
|
Total
|
26/125 (20.8)
|
14/120 (11.7)
|
|
Disorders of screening panel 2005 without PKU and BIOD$
|
8/61 (13.1)
|
5/60 (8.3)
|
|
Additional disorders screened until 2005#
|
11/14 (78.6)
|
5/11 (45.5)
|
- Abbreviations see Table 1
- * ≥ 1 disorder specific clinical sign
- $ MSUD, Galactosaemia, MCADD, LCHADD, VLCADD, CPT ID, CPT IID, GA I, IVA
- # Cobalamin C/D defect, PA, HMG-CoA LD, CIT I, ASLD, TYR I, CTD, MADD
